Adrian M. Dubuc, PhD, FACMG

I am a Cytogeneticist and Molecular Geneticist who has spent my career attempting to bridge the gap between research innovation and integration of genomic studies into clinical care.

I completed my undergraduate degree in Biochemistry and Biotechnology from Carleton University (Ottawa, Canada) and went onto to obtain my doctorate from Dr. Michael Taylor's laboratory at the Hospital for Sick Children and University of Toronto, performing 'omics' based analysis of the pediatric brain tumor medulloblastoma. At Harvard medical School, I completed my American Board of Medical Genetics and Genomics (ABMGG) training in Cytogenetics (2015) and Molecular Genetics (2017), before joining staff at Brigham and Women’s Hospital (2015) where I served as a faculty Cytogeneticist and Molecular Geneticist for 8-years, before joining Roswell Park Comprehensive Cancer Center in 2023. 

I have published over 80-peer reviewed publications and contributed to numerous practice guidelines, including American College of Medical Genetics (ACMG) evidence-based guidelines and quality assurance measures. My work has been recognized through >50 talks at national and international meetings. I have served as the a former Program Chair of the Cancer Genomics Consortium (CGC) Annual Meeting (2019), President of the CGC (2020) and as a member of the ACMG’s Cytogenetics Laboratory Quality Assurance Committee. I am passionate about improving the effective use of cytogenetics/genomics to ensure appropriate and accurate diagnosis, and management, for all patients.